The Breast Cancer Research Foundation
|Founder||Evelyn H. Lauder|
|Focus||Breast Cancer Research|
|Key people||Myra J. Biblowit, President|
|Slogan||Prevention and A Cure in our Lifetime|
The Breast Cancer Research Foundation (BCRF) is an independent, not-for-profit organization which has raised USD $350 million to support clinical and translational research at medical institutions worldwide. BCRF currently funds 186 scientists across the United States, Canada, Latin America, Europe, the Middle East, Australia, and Asia.
The BCRF's director of research is Dr. Larry Norton of Memorial Sloan-Kettering Cancer Center. BCRF has funded basic research on genetic susceptibility to breast cancer, breast cancer stem cells, trastuzumab (Herceptin), anti-angiogenesis treatment with bevacizumab (Avastin), MRI imaging, aromatase inhibitors, tamoxifen; and also clinical trials of new treatments with the Translational Breast Cancer Research Consortium.
BCRF was founded in 1993 by Evelyn Lauder, Senior Corporate Vice President of The Estee Lauder Companies. Lauder's first foray into breast cancer awareness was through an initiative by herself and Alexandra Penney, former editor of SELF magazine, to make the pink ribbon an international symbol of breast cancer awareness.
Funding and spending
As of 2013, BCRF directs more than 90 cents of every dollar raised to breast cancer research and breast cancer awareness programs. BCRF has received exceptional recognition from several organizations that monitor and provide comprehensive, unbiased information on charities. CharityWatch, formerly the American Institute of Philanthropy, continues to award BCRF an "A+" rating.
- "BCRF Grantees". The Breast Cancer Research Foundation.
- our impact: The Breast Cancer Research Foundation: What We've Accomplished
- "Breast Cancer Awareness Campaign". The Estée Lauder Companies Inc.
- "Responsible Giving and Efficiencies". The Breast Cancer Research Foundation.
- "Top Rated Charities". CharityWatch.